{"id":"W4408206616","doi":"10.1007/s12325-025-03138-2","title":"A Randomised, Double-Blind Trial to Compare the Efficacy, Safety, and Immunogenicity of the Biosimilar Ustekinumab FYB202 with Reference Ustekinumab in Patients with Moderate-to-Severe Plaque Psoriasis","year":2025,"lang":"en","type":"article","venue":"Advances in Therapy","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; University of Toronto","funders":"","keywords":"Ustekinumab; Medicine; Psoriasis Area and Severity Index; Biosimilar; Randomized controlled trial; Internal medicine; Clinical endpoint; Adverse effect; Psoriasis; Dermatology; Infliximab; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002901113,0.001657082,0.003354108,0.0005038718,0.0006256239,0.0008565036,0.001037374,0.002315116,0.00999719],"category_scores_gemma":[0.002780732,0.0009080155,0.001770485,0.0004596951,0.001640126,0.001183206,0.0006324548,0.001928109,0.001717192],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008532932,"about_ca_system_score_gemma":0.00151434,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006451633,"about_ca_topic_score_gemma":0.001097607,"domain_scores_codex":[0.9987075,0.0007125867,0.0001082263,0.0002399787,0.000099308,0.0001323943],"domain_scores_gemma":[0.998181,0.0005500927,0.000497909,0.0001883385,0.0001332947,0.0004495092],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9907681,0.004549425,0.0001715978,0.0001492718,0.0001623121,0.00001284073,0.00002157536,0.00007499407,0.001005574,0.00003668311,0.000137928,0.002909772],"study_design_scores_gemma":[0.9529848,0.04606948,0.0004324372,0.000009844361,0.00006641127,0.00001334253,0.000005519516,0.00009743399,0.0001202069,0.00004675072,0.000148099,0.000005605201],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9836057,0.002240403,0.000931379,0.0004643796,0.0006274849,0.009618637,0.0007948115,0.00008286739,0.001634259],"genre_scores_gemma":[0.9778298,0.001096184,0.002038471,0.000835562,0.0005680683,0.01376598,0.0008190941,0.00001576718,0.003031163],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00999719,"threshold_uncertainty_score":0.03344393,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02167875285679234,"score_gpt":0.3021284946839793,"score_spread":0.280449741827187,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}